Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.5 CAD | -11.17% | +4.48% | +20.69% |
05-17 | XORTX Therapeutics Reprices Warrants Connected With U.S. IPO | MT |
05-17 | XORTX Therapeutics Brief: Says Repriced Balance of Warrants Issued in Connection with October 2021 US IPO | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+20.69% | 7.43M | |
+12.30% | 118B | |
+12.15% | 106B | |
-8.14% | 23.4B | |
-1.69% | 21.78B | |
-10.60% | 18.09B | |
-41.25% | 16.72B | |
-15.33% | 15.97B | |
+5.80% | 14.03B | |
+28.03% | 11.67B |
- Stock Market
- Equities
- XRTX Stock
- News XORTX Therapeutics Inc.
- XORTX Therapeutics Brief: Appointing James Fairbairn as Chief Financial Officer to replace Amar Keshri who left the Co's employ effective July 31, 2023; Fairbairn was appointed Interim CFO on June 28, 2023